Neurofibromatosis

Cognition and Cancer

Volumn , Issue , 2008, Pages 211-227

  Moore, Bartlett D ^a   Slopis, John M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64549131414     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545900.016     Document Type: Chapter

References (79)

1. Ablon J (1995). “The Elephant Man” as “self” and “other”: the psycho-social costs of a misdiagnosis. Soc Sci Med 40: 1481-1489.
2. Alivisatos B, Petrides M (1997). Functional activation of the human brain during mental rotation. Neuropsychologia 35:111-118.
3. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (4th edn.) (Test Revision). DSM-IV-TR. Arlington, VA: American Psychiatric Association.
4. Aoki S, Barkovich AJ, Nishimura K et al. (1989). Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 172: 527-534.
5. Bale SJ, Amos CI, Parry DM et al. (1991). Relationship between head circumference and height in normal adults and in the nevoid basal cell carcinoma syndrome and neurofibromatosis type I. Am J Med Genet 40: 206-210.
6. Balestri P, Vivarelli R, Grosso S et al. (2003). Malformations of cortical development in neurofibromatosis type 1. Neurology 61:1799-1801.
7. Billingsley RL, McAndrews MP, Crawley AP et al. (2001). Functional MRI of phonological and semantic processing in temporal lobe epilepsy. Brain 124: 1218-1227.
8. Billingsley RL, Schrimsher GW, Jackson EF et al. (2002). Significance of planum temporale and planum pariet ale morphologic features in neurofibromatosis, type I. Arch Neurol 59: 616-622.
9. Billingsley RL, Jackson EF, Slopis JM et al. (2003a). Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1. J Child Neurol 18: 731-740.
10. Billingsley RL, Slopis JM, Swank PR et al. (2003b). Cortical morphology associated with language function in neurofibromatosis, type I. BrainLang 85: 125-139.
11. Billingsley RL, Jackson EF, Slopis JM et al. (2004). Functional MRI of visual-spatial processing in neurofibromatosis, type I. Neuropsychologia 42: 395-404.
12. Booth JR, MacWhinney B, Thulborn KR, et al. (2000). Developmental and lesion effects in brain activation during sentence comprehension and mental rotation. DevNeu- ropsychol 18:139-169.
13. Brewer VR, Moore BD, Hiscock M (1997). Learning disability subtypes in children with neurofibromatosis. J Learn Disabil 30: 521-533.
14. Cawthon RM, Weiss R, Xu GF, et al. (1990). A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations [published erratum appears in Cell 1990 Aug 10:62(3):following608]. Cell 62:193-201.
15. Clark MM, Plante E (1998). Morphology of the inferior frontal gyrus in developmentally language-disordered adults. Brain Lang 61: 288-303.
16. Costa RM, Federov NB, Kogan JH, et al. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415: 526-530.
17. Coude FX, Mignot C, Lyonne S et al. (2004). Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children. Behav Genet 34: 635.
18. Crump T (1981). Translation of case reports in Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen [On Multiple Fibromas of the Skin and their Relationship to Multiple Neuromas] by F. V. Recklinghausen. In Riccardi VM, Mulvihill J (eds.) Neurofibromatosis (von Recklinghausen Disease): Genetics, Cell Biology, and Biochemistry (Vol. 23, pp. 259-275). New York: Raven Press.
19. Cutting LE, Koth CW, Denckla MB (2000). How children with neurofibromatosis type 1 differ from “typical” learning disabled clinic attenders: nonverbal learning disabilities revisited. Dev Neuropsychol 17: 29-47.
20. De Winter AE, Moore BD, Slopis JM et al. (1999). Brain tumors in children with neurofibromatosis: additional neuropsychological morbidity? Neurooncology 1: 275-281.
21. Denckla MB, Hofman K, Mazzocco MM et al. (1996). Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 67: 98-102.
22. Descheemaeker MJ, Ghesquiere P, Symons H et al. (2005). Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children. JIntellect Disabil Res 49: 33-46.
23. DiPaolo DP, Zimmerman RA, Rorke LB et al. (1995). Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 195: 721-724.
24. Duffner P, Cohen M, Seidel F, et al. (1989). The significance of MRI abnormalities in children with neurofibromatosis. Neurology 39: 373-378.
25. Dunn DW, Roos KL (1989). Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis. Neurofibromatosis 2:1-5.
26. Eden GF, Stein JF, Wood HM et al. (1996a). Differences in visuospatial judgement in reading-disabled and normal children. Percept Motor Skills 82:155-177.
27. Eden GF, VanMeter JW, Rumsey JM et al. (1996b). Abnormal processing of visual motion in dyslexia revealed by functional brain imaging [see comments]. Nature 382: 66-69.
28. Eden GF, VanMeter JW, Rumsey JM, et al. (1996c). The visual deficit theory of developmental dyslexia. Neuroimage 4: S108-S117.
29. Eldridge R, Denckla MB, Bien E et al. (1989). Neurofibromatosis type 1 (Recklinghausen’s disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child 143: 833-837.
30. Eliason MJ (1986). Neurofibromatosis: implications for behavior and learning. Neurofibromatosis 7:175-179.
31. Eliason MJ (1988). Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1:17-25.
32. Ferner RE, Chaudhuri R, Bingham J et al. (1993). MRI in neurofibromatosis 1: the nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492-495.
33. Ferner RE, Hughes RA, Weinman J (1996). Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138: 125-133.
34. Fletcher JM, Shaywitz SE, Shankweiler DP, et al. (1994). Cognitive profiles of reading disability: comparisons of discrepancy and low achievement definitions. J Educ Psychol 86:6-23.
35. Goh WHS, Khong PL, Leung CSY et al. (2004). T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: Their impact on cognitive function. J Child Neurol 19: 853-858.
36. Greenlee MW, Magnussen S, Reinvang I (2000). Brain regions involved in spatial frequency discrimination: evidence from fMRI. Exp Brain Res 132: 399-403.
37. Guo HF, Tong JY, Hannan F et al. (2000). A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 403: 895-898.
38. Gutmann DH, Aylsworth A, Carey JC, et al. (1997). The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. J Am Med Assoc 278: 51-57.
39. Hofman KJ, Harris EL, Bryan RN et al. (1994). Neurofibromatosis type 1: the cognitive phenotype. J Pediatr 124: S1-S8.
40. Itoh T, Magnaldi S, White RM et al. (1994). Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNRAm J Neuroradiol 15: 1513-1519.
41. Kayl AE, Moore B, Slopis JM, et al. (2000). Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention deficit hyperactivity disorder. J Child Neurol 15: 90-96.
42. Korf BR, Rubenstein AE (2005). Neurofibromatosis: A Handbook for Patients, Families, and Health Care Professionals (2nd edn.). New York: Thieme Medical Publications.
43. Kortmann RD, Timmermann B, Taylor RE, et al. (2003). Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 179: 585.
44. Leonard CM, Eckert MA, Lombardino LJ et al. (2001). Anatomical risk factors for phonological dyslexia. Cerebral Cortex 11: 148-157.
45. Lindgren SD, Benton AL (1980). Developmental patterns of visuospatial judgment. J Pediatr Psychol 5: 217-225.
46. Listernick R, Louis DN, Packer RJ et al. (1997). Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41: 143-149.
47. Margariti PN, Blekas K, Katzioti FG, et al. (2007). Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1. Eur Radiol 17:433-438.
48. Mazzocco MM, Turner JE, Denckla MB et al. (1995). Language and reading deficits associated with neurofibro- matosistype 1: evidence for a not-so-nonverbal learning disability. Dev Neuropsychol 11: 503-522.
49. Moore BD, Denckla MB (1999). Neurofibromatosis. In Yeates K, Ris M, Taylor H (eds.) Pediatric Neuropsychology: Research, Theory, and Practice. New York: Guilford Publications, Inc.
50. Moore BD, Ater JL, Needle MN, et al. (1994). Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol 9: 368-377.
51. Moore BD, Slopis JM, Schomer D et al. (1996). Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660-1668.
52. Moore BD, Slopis JM, Jackson EF et al. (2000). Brain volume in children with neurofibromatosis, type 1: relation to neuropsychological status. Neurology 54: 914-920.
53. Mulvihill JJ, Parry DM, Sherman JL et al. (1990). Neurofibromatosis-1 (Recklinghausen Disease) and neurofibromatosis-2 (bilateral acoustic neurofibromatosis) - an update. Ann IntMed 113: 39-52.
54. National Insitutes of Health (1988). Consensus development conference: neurofibromatosis conference statement. Arch Neurol 45: 575-578.
55. North K, Joy, P, Yuille D, et al. (1994). Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities [see comments]. Neurology 44: 878-883.
56. North KN, Riccardi V, Samango-Sprouse C et al. (1997). Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48: 1121-1127.
57. Packer RJ, Gutmann DH, Rubenstein A, et al. (2002). Plexi- form neurofibromas in NF1: toward biologic-based therapy Neurology 58(10): 1461.
58. Paulesu E, Frith U, Snowling M, et al. (1996). Is developmental dyslexia a disconnection syndrome? Evidence from PET scanning. Brain 119 (Pt 1): 143-157.
59. Pavol M, Hiscock M, Massman P et al. (2006). Neuropsychological function in adults with von Recklinghausen’s neurofibromatosis. Dev Neuropsychol 29: 509-526.
60. Pugh KR, Shaywitz BA, Shaywitz SE et al. (1996). Cerebral organization of component processes in reading. Brain 119:1221-1238.
61. Riccardi VM (1981). Von Recklinghausen neurofibromatosis. NEngl JMed 305:1617-1627.
62. Riccardi V, Eichner J (1986). Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore, MD: Johns Hopkins University.
63. Rourke BP (1989). Nonverbal Learning Disabilities. New York: Guilford Press.
64. Said SM, Yeh TL, Greenwood RS et al. (1996). MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport 7: 1941-1944.
65. Schrimsher GW, Billingsley RL, Slopis JM et al. (2003). Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genetics Part A 120A: 326-330.
66. Sevick RJ, Barkovich AJ, Edwards MS, et al. (1992). Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJRAm J Roentgenol 159:171-175.
67. Sharif S, Ferner R, Birch JM et al. (2006). Second primary tumors in neurofibromatosis I patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24: 2570-2575.
68. Shaywitz SE, Shaywitz BA, Pugh KR, et al. (1998). Functional disruption in the organization of the brain for reading in dyslexia. Proc Natl Acad Sci USA 95: 2636-2641.
69. Silva AJ, Frankland PW, Marowit Z et al. (1997). A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 15: 281-284.
70. Stanovich KE (1988). Explaining the differences between the dyslexic and the garden-variety poor reader: the phonological-core variable-difference model. J Learn Disabil 21: 590-604.
71. Temple E, Poldrack RA, Protopapas A et al. (2000). Disruption of the neural response to rapid acoustic stimuli in dyslexia: evidence from functional MRI. Proc Natl Acad Sci USA, 97: 13907-13912.
72. Temple E, Poldrack RA, Salidis J et al. (2001). Disrupted neural responses to phonological and orthographic processing in dyslexic children: an fMRI study. Neuroreport 12: 299-307.
73. Uhlmann EJ, Gutmann DH (2001). Tumor suppressor gene regulation of cell growth - recent insights into neurofibromatosis 1 and 2 gene function. Cell Biochem Biophys 34: 61-78.
74. Viskochil D, Buchberg AM, Xu G, et al. (1990). Deletions and atranslocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192.
75. von Deimling A, Krone W, Menon AG (1995). Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153-162.
76. Wadsby M, Lindehammar H, Eeg-Olofsson O (1989). Neurofibromatosis in childhood: neuropsychological aspects. Neurofibromatosis 2: 251-260.
77. Wallace MR, Marchuk DA, Andersen LB et al. (1990). Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients [published erratum appears in Science 1990 Dec 21; 250(4988): 1749]. Science 249: 181-186.
78. Zhu Y, Romero MI, Ghosh P, et al. (2001). Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15: 859-876.
79. Zvulunov A, Weitz R, Metzker A (1998). Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity. Clin Pedi- atr (Phila) 37: 295-299.